Diagnostic anti-Erythropoetin (EPO) antibodies (anti-Erythropoetin, anti-EPO) and diagnostic hapten-carrier conjugates BSA-Erythropoetin (EPO), OVA-Erythropoetin (EPO), KLH-Erythropoetin (EPO) antigens for Hormone disorders EPO detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Genemedi produces core diagnostic ingredients for test of Hormone disorders (Anemia, polycythemia or erythrocytosis, hypertension) and related syndrome. GeneMedi offers paired anti-Erythropoetin (EPO) antibodies (monoclonal antibody, mab) and Erythropoetin (EPO antigens (Carrier-coupled antigen, immunogen, hapten-carrier conjugates, BSA-conjugated, OVA-conjugated, KLH-conjugated) for Hormone disorders (Anemia, polycythemia or erythrocytosis, hypertension) rapid test kit of Erythropoetin (EPO) testing in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. The carrier-coupled antigens of small molecules can act as immunogens.Erythropoietin (EPO) is produced and released into the blood by the kidneys in response to low blood oxygen levels (hypoxemia). The amount of erythropoietin released depends on how low the oxygen level is and the ability of the kidneys to produce erythropoietin. EPO is carried to the bone marrow, where it stimulates production of red blood cells. The hormone is active for a short period of time and then eliminated from the body in the urine. However, if kidneys are damaged and do not produce enough erythropoietin, then too few RBCs are produced and leads to anemic. Similarly, if bone marrow is unable to respond to the stimulation from EPO also become anemic. This can occur with some bone marrow disorders or with chronic diseases, such as rheumatoid arthritis. The erythropoietin production increased with some benign or malignant kidney tumors and with a variety of other cancers, it also produces too many RBCs?(polycythemia or erythrocytosis). This can lead to an increase in the blood’s thickness (viscosity) and sometimes to high blood pressure (hypertension), blood clots (thrombosis), heart attack, or stroke. Rarely, polycythemia is caused by a bone marrow disorder called polycythemia vera, not by increased erythropoietin.